Sílvia Pascual
5 Papers
Sílvia Pascual is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Ab0020 cytochemical assessment in treg cells of psoriasic arthropathy by inhibition of il23 (in real life) and its correlation with clinical remission
F. N. Navarro Blasco,Sílvia Pascual +1 more
TL;DR: Koenen et al. as mentioned in this paper used flow cytometry to identify the cytokine profile of IL-10 and IL-17 in CD4+FoxP3+ cells of patients with PsA and correlate the expression of these molecules and the state of minimal activity of the disease.
1
Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trial
Ángeles García-Cazorla,Caroline Sevin,Juliana R Constante,Elise Yazbeck,Hendrik Rosewich,Sandra Jimenez,Gloria Chia-Yi Chiang,Otto Rapalino,Paul Caruso,Daniel Balentine,Karl G. Helmer,Seth Bennett,Marco Emanuele,Laura Rodríguez-Pascau,Pilar Pizcueta,Guillem Pina,Anna Vilà,Maria Rovira,Adriana Mantilla,U. Meya,Arun Mistry,María Pascual,Sílvia Pascual,Marc Martinell,Patricia L. Musolino,Eric J. Mallack +25 more
1
Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial
Wolfgang Köhler,Marc Engelen,Florian Eichler,Robin H. Lachmann,Ali Fatemi,Jacinda B. Sampson,Ettore Salsano,Josep Gamez,Márk Molnár,Sílvia Pascual,Maria Rovira,Anna Vilà,Guillem Pina,Itziar Martin-Ugarte,Adriana Mantilla,Pilar Pizcueta,Laura Rodríguez-Pascau,E. Traver,Anna Vilalta,María Rosa Querol Pascual,Marco Martiniello,U. Meya,Fanny Mochel,Eavan Mc Govern,Elise Yazbeck,Magali Barbier,Marie-Pierre Luton,Françoise Pousset,Jean-Yves Hogrel,Isaac M. Adanyeguh,Florian Then Bergh,Caroline G. Bergner,A. Unterlauft,Hannes Roicke,Karl-Titus Hoffmann,C. Scherlach,A. Al Kalb,Bianca Meilick,Mandy Reuschel,S Fenu,Elena Mauro,Elaine Murphy,G Sivarama Krishna,Tiggy Beyene,Alba Sierra,Sara Quiñoa,Anna Belen Canovas,Zoltán Grosz,Báthori Györgyi,S. I. V. D. Stadt,Irene C. Huffnagel,Wouter J.C. Van Ballegoij,M. Voermans,Reza Seyedsadjadi,Camille Corre,N. Godbole,Natalie Grant,Claudia Maria Brito Pires,M. K. Trovato,Nancy Yeh,J. Robyn Goodman,Jennifer Keller,Chris Joseph,Keith Van Haren,Sarada Sakamuri,Tina Duong,Lila A Perrone,Stephanie Tran,Sally Dunaway Young,S. Hashmi +69 more
TL;DR: The finding that cerebral adrenoleukodystrophy, a life-threatening event for patients with adrenomyeloneuropathy, occurred only in patients in the placebo group supports further investigation of whether leriglitazone might slow the progression of cerebral adrenoleskystrophy.
Oral leriglitazone as an effective therapeutic strategy to treat neuro inflammation in metachromatic leukodystrophy
Caroline Sevin,E. Banchi,Rafael Alonso,Julie Revemont,Kevin Fransquin,Anna Vilalta,Pilar Pizcueta,Laura Rodriguez,Sílvia Pascual,Françoise Piguet +9 more
Myelin content monitoring by diffusion biomarkers in a therapeutic trial with leriglitazone in men with adrenomyeloneuropathy (P1-1.Virtual)
Vincent Perlbarg,Sílvia Pascual,Bernardo Blanco,Magali Barbier,Elise Yazbeck,Dorothee Uriet,Julie Rachline,Uwe Meya,Marc Martinell,Damien Galanaud,Marc Engelen,Fanny Mochel +11 more